Label: MEDIS SODIUM BICARBONATE- sodium bicarbonate powder
- NDC Code(s): 0802-2685-94
- Packager: Humco Holding Group, Inc
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Updated March 17, 2022
If you are a consumer or patient please visit this version.
- SPL UNCLASSIFIED SECTION
- Active Ingredient
NOT FOR INJECTIONS
Except under supervision of a doctor do not administer to children under 6 years of age.
Do not take more than six, 1/2 tsp. per person up to 60 years old, or three 1/2 tsp. per person 60 years or older in a 24 hour period.
Do not use this product if you are on a sodium restricted diet (each 1/2 tsp. contains 30 mEq (0.7 g) Sodium).
Do not use the maximum does more than 2 weeks.
- Ask a doctor or pharmacist before use if
- Keep out of reach of children.
- Inactive ingredients
INGREDIENTS AND APPEARANCE
MEDIS SODIUM BICARBONATE
sodium bicarbonate powder
Product Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:0802-2685 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SODIUM BICARBONATE (UNII: 8MDF5V39QO) (SODIUM CATION - UNII:LYR4M0NH37) SODIUM BICARBONATE 1000 mg in 1 g Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:0802-2685-94 113 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product 11/09/2017 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part331 11/09/2017 Labeler - Humco Holding Group, Inc (825672884) Registrant - Pharma Nobis, LLC (118564114) Establishment Name Address ID/FEI Business Operations Pharma Nobis, LLC 118564114 label(0802-2685) , manufacture(0802-2685) , pack(0802-2685) , analysis(0802-2685)